Pregnancy and Fibrin Clot Properties

ConditionsFibrin Blood Clot Pregnancy Pregnancy Complicated by Cardiovascular Disorders as Postpartum Condition, Delivered During Previous Episode

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18-40

SponsorJagiellonian University

About this trial

1. The structure of fibrin clot and thrombin generation may vary between trimesters of pregnancy. 2. Unfavorably altered fibrin clot properties along with enhanced thrombin generation may lead to the development of complications during pregnancy such as TE and hypertensive disorders. 3. The application of machine learning techniques may help to identify previously undetected phenotypes with increased risk of TE and hypertensive disorders during pregnancy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Two groups: 1. Healthy pregnant women 2. Pregnant women with hypertensive disorders during pregnancy

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

analysis of fibrin clot properties and thrombin generation
Diagnostic test
determination of fibrin clot properties and thrombin generation

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: Healthy pregnant women1 intervention

Group B: Pregnant women with hypertensive disorders during pregnancy1 intervention

Trial outcomes

Primary outcomes

Fibrin clot phenotype

Time frame

12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jagiellonian University

Lead sponsor

Source ClinicalTrials.gov

Apply now